BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 28874476)

  • 1. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.
    Podnecky NL; Wuthiekanun V; Peacock SJ; Schweizer HP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4381-6. PubMed ID: 23817379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.
    Rhodes KA; Somprasong N; Podnecky NL; Mima T; Chirakul S; Schweizer HP
    Microbiology (Reading); 2018 Sep; 164(9):1156-1167. PubMed ID: 30024368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
    Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
    Schweizer HP
    Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b.
    Kumar A; Chua KL; Schweizer HP
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3460-3. PubMed ID: 17005832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.
    Webb JR; Price EP; Somprasong N; Schweizer HP; Baird RW; Currie BJ; Sarovich DS
    Future Microbiol; 2018 Sep; 13(12):1403-1418. PubMed ID: 30256166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
    Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
    Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic resistance in Burkholderia species.
    Rhodes KA; Schweizer HP
    Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of resistance-nodulation-cell-division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia.
    Kumar A; Mayo M; Trunck LA; Cheng AC; Currie BJ; Schweizer HP
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S145-51. PubMed ID: 19121677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
    Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.
    Schnetterle M; Gorgé O; Nolent F; Boughammoura A; Sarilar V; Vigier C; Guillier S; Koch L; Degand N; Ramisse V; Tichadou X; Girleanu M; Favier AL; Valade E; Biot F; Neulat-Ripoll F
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0008913. PubMed ID: 33592059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
    Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC;
    J Antimicrob Chemother; 2001 Dec; 48(6):935-6. PubMed ID: 11733486
    [No Abstract]   [Full Text] [Related]  

  • 14. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 16. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.